GREENSANDS (POTTON) — All Prescriptions & Medications — Page 12
Practice Code: E81012 | SANDY, SG19 2QS
Showing results 551-600 of 635
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Olmesartan medoxomil/amlodipine | 14 | 392 | £226 | +6.1% ▲ |
| Mometasone/glycopyrronium/indacaterol | 14 | 420 | £554 | -7.6% ▼ |
| Erdosteine | 14 | 416 | £100 | +45.9% ▲ |
| Levomepromazine maleate | 14 | 392 | £3.5K | +52.4% ▲ |
| Oxcarbazepine | 14 | 1,552 | £253 | -49.9% ▼ |
| Ready to serve 1.5 kcal/ml milkshake with fibre (0913021) | 14 | 199.2K | £5.0K | +1.4% vs avg |
| Tube feed 1.5 kcal/ml peptide based (0914041) | 14 | 359.0K | £11.7K | +31.5% ▲ |
| Cyclopentolate hydrochloride | 14 | 135 | £217 | +144.8% ▲ |
| 14 | 131 | £125 | +131.9% ▲ | |
| Propafenone hydrochloride | 13 | 1,124 | £111 | +20.1% ▲ |
| Captopril | 13 | 728 | £231 | -10.2% ▼ |
| Enalapril maleate with diuretic | 13 | 364 | £292 | +35.3% ▲ |
| Indacaterol/glycopyrronium | 13 | 390 | £402 | -71.2% ▼ |
| Guanfacine | 13 | 364 | £941 | -49.4% ▼ |
| Zonisamide | 13 | 728 | £327 | -70.2% ▼ |
| Rasagiline mesilate | 13 | 364 | £220 | -65.0% ▼ |
| Rifaximin | 13 | 728 | £3.4K | -51.6% ▼ |
| Metformin hydrochloride/pioglitazone | 13 | 728 | £444 | +2.9% ▲ |
| Testosterone undecanoate | 13 | 13 | £1.0K | -48.8% ▼ |
| Other oral iron preparations | 13 | 350 | £95 | +31.7% ▲ |
| Ketorolac trometamol | 13 | 70 | £48 | +40.1% ▲ |
| 13 | 65 | £24 | -55.1% ▼ | |
| 13 | 20 | £92 | -68.1% ▼ | |
| Nicardipine hydrochloride | 12 | 672 | £68 | +19.6% ▲ |
| Valsartan/amlodipine | 12 | 336 | £296 | +9.4% ▲ |
| Prasugrel | 12 | 336 | £45 | -61.8% ▼ |
| Chlorpromazine hydrochloride | 12 | 126 | £83 | -69.5% ▼ |
| Cinnarizine | 12 | 903 | £45 | -74.4% ▼ |
| Domperidone | 12 | 351 | £8 | -66.4% ▼ |
| Clobazam | 12 | 360 | £41 | -81.8% ▼ |
| Acarbose | 12 | 1,344 | £370 | +2.8% ▲ |
| Vardenafil | 12 | 48 | £106 | -14.1% ▼ |
| Powder thickener - starch based (0913161) | 12 | 3,780 | £106 | -16.5% ▼ |
| Acetic acid | 12 | 60 | £55 | +3.6% ▲ |
| Fluocinolone acetonide | 12 | 650 | £94 | +10.2% ▲ |
| Amorolfine hydrochloride | 12 | 60 | £76 | -48.0% ▼ |
| 12 | 530 | £282 | -67.7% ▼ | |
| 12 | 22 | £537 | +31.7% ▲ | |
| 12 | 630 | £1.1K | +48.5% ▲ | |
| 12 | 850 | £84 | -75.1% ▼ | |
| Moclobemide | 11 | 660 | £182 | -15.1% ▼ |
| Reboxetine | 11 | 990 | £298 | -28.6% ▼ |
| Hyoscine hydrobromide | 11 | 924 | £148 | -67.8% ▼ |
| Bupropion hydrochloride | 11 | 330 | £219 | +1.8% vs avg |
| Tetracycline | 11 | 1,232 | £918 | +135.2% ▲ |
| Empagliflozin/metformin | 11 | 616 | £358 | -78.9% ▼ |
| Metformin hydrochloride/vildagliptin | 11 | 330 | £188 | -32.7% ▼ |
| Combined ethinylestradiol 35mcg | 11 | 945 | £51 | -11.7% ▼ |
| Magnesium glycerophosphate | 11 | 830 | £603 | -19.9% ▼ |
| Ergocalciferol | 11 | 330 | £44 | -34.3% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.